热搜: Offer BD CC JD
查看: 6406|回复: 0

[行业资讯] GSK CEO 到访中国危机公关

发表于 2013-12-4 13:09:08 | 显示全部楼层 |阅读模式
葛兰素史克首席执行官Andrew Witty不希望此前在中国发生的行贿事件对其在华业务产生影响。近日Witty与其他一百多名英国商界领袖随英国首相卡梅隆来到中国开展经贸会谈。
GlaxoSmithKline ($GSK) CEO Andrew Witty isn't allowing bribery allegations against his company in China to sway his determination to do business there. At least that's what GSK is saying today, as Witty joins U.K. prime minister David Cameron and 100 other business execs on a trade mission to the country.
It's Witty's first visit to China since authorities there alleged in July that the company funneled about $490 million in bribes through travel agencies to Chinese doctors to meet aggressive sales-growth targets. GSK's sales in China plummeted 61% in the quarter ended in September, as hospitals there turned away the British company's salespeople in the wake of the ensuing investigation.
Witty declined to comment on the investigation in a Reuters report on today's trade mission, but a GSK spokesman called the CEO's tour "an important opportunity to show our continued commitment to China and to supplying our medicines to the country."
GSK has been under fire since the scandal erupted, and not just in China. In September, the U.S. Justice Department began investigating China's allegations. Because GSK's shares are listed in the U.S., the company is vulnerable to prosecution under the Foreign Corrupt Practices Act (FCPA), which prohibits paying overseas officials for the purpose of winning or retaining business.
Several pharma companies have acknowledged probes under the FCPA of late, including Merck ($MRK), AstraZeneca ($AZN) and Eli Lilly ($LLY). GSK could also face scrutiny under Britain's anticorruption laws. Company officials continue to maintain they did not know about the alleged bribes in China.
The only bit of good news in this China drama came in early November, when reports emerged that GSK likely won't be facing corruption charges there. Still, its Chinese executives might be charged, and authorities are reportedly weighing "astronomical" fines against the company.
Witty told Reuters today that GSK would have more news on the China investigation "quite soon."
您需要登录后才可以回帖 登录 | 注册  


QQ|邮件|Archiver|手机版|小黑屋|职海领航 ( 沪ICP备17019760号-1  

GMT+8, 2018-12-16 07:23 , Processed in 0.443434 second(s), 43 queries .

Powered by Discuz! X3.4

© 2001-2017 Comsenz Inc.

快速回复 返回顶部 返回列表